97222990 - SYNVANT

Information

• Trademark
• 97222990

• Source

• Serial Number

  97222990

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 16 - Paper, cardboard and goods made from these materials, not included in other classes
  • 35 - Advertising
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  January 17, 2022
  2 years ago

• Transaction Date

  January 22, 2024
  7 months ago

• Status Date

  January 22, 2024
  7 months ago

• Published for Opposition Date

  April 25, 2023
  a year ago

• Location Date

  June 20, 2023
  a year ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  BHANOT, KAPIL KUMAR

• Attorney Docket Number

  077752-13

  Attorney Name

  Mark A. Watkins

  Law Office Assigned Location Code

  L80

• Owners

  • SYNGENE INTERNATIONAL LTD

Case File Statements

• GS0051: Biological and biotechnological chemicals and chemical preparations and formulations thereof for pharmaceutical and medical use pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; antibodies for use in disease testing; synthetic peptides for pharmaceutical purposes pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for use in oncology; biological tissue grafts; biopharmaceuticals for the treatment of cancer; protein arrays for use in recombinant DNA technology for medical and diagnostic purposes; regulatory proteins for medical diagnostic use; biological preparations for medical purposes for treating disease and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, meningitis, asthma, diabetes, multiple sclerosis, acne; chemical preparations for use in DNA analysis for diagnostic and treatment purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; none of the aforesaid goods relating to gel imaging and gel analysis applications and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes
• GS0161: Paper and cardboard; printed matter, namely, catalogs and brochures in the field of biotechnology; Bookbinding materials for creating hardcover books, namely, book covers, crackand-peel binding paper, reinforcement strips, peel-and-stick labels, stapler and staples; printed photographs; Plastic sheets, films and bags for wrapping and packaging; Plastic film for packaging; paper tags; paper bags for packaging; printed business cards; Bags of paper or plastics for packaging; printed vouchers
• GS0351: Maintaining patient medical records and files; Advertising research; Business research services; Market analysis and research services; Compilation of statistical data relating to medical research; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare
• GS0011: Biotechnological products and preparations for laboratory use, namely, enzymes, proteins, carbohydrates, lipids, nucleic acids, DNA, immunological re-agents, and organic intermediates being fine chemicals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne, meningitis, asthma; chemicals for industrial use; assays for research purposes; unprocessed chemical polymers; chemicals for use in biotechnological product development; cells for scientific, laboratory or medical research; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; proteins for use in recombinant DNA technology for laboratory use; chemicals being reference standards for use in science and industry; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for use in vitro scientific research; assays for research purposes(duplicate entry); diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; none of the aforesaid goods relating to gel imaging and gel analysis applications and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes
• GS0441: Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; pathology services for medical and medical diagnostic purposes; medical testing services
• GS0421: Pharmaceutical research and development; medical and scientific research services in the field of cancer treatment and diagnosis, cardiology, nephrology, endocrinology; chemical, biochemical, biological and bacteriological research and analysis; Research and development in the field of diagnostic preparations; Biomedical research services; Computer aided scientific research, testing and analysis services; in the fields of medicine and pharmaceuticals; Compiling data for research purposes in the field of medical science and medical consultancy; Scientific research and custom design of pharmaceuticals; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; research and development services in the field of antibodies, antibody technology; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials for scientific research for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; DNA analysis services for scientific research purposes; blood analysis services for scientific research purposes; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; scientific and medical laboratory services; services of a chemical and biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, and solid state characterization; none of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculture, horticulture and forestry

Case File Event Statements

• 1/22/2024 - 7 months ago

  25 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 1/22/2024 - 7 months ago

  24 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 6/20/2023 - a year ago

  23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 4/25/2023 - a year ago

  22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/25/2023 - a year ago

  21 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/5/2023 - a year ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 3/22/2023 - a year ago

  19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/22/2023 - a year ago

  18 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/22/2023 - a year ago

  17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/22/2023 - a year ago

  16 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/22/2023 - a year ago

  15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/9/2023 - a year ago

  14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/9/2023 - a year ago

  13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/9/2023 - a year ago

  12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/12/2022 - a year ago

  11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/12/2022 - a year ago

  10 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/12/2022 - a year ago

  9 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/1/2022 - a year ago

  8 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 11/1/2022 - a year ago

  7 - PRIORITY ACTION E-MAILED Type: GPRA

• 11/1/2022 - a year ago

  6 - PRIORITY ACTION WRITTEN Type: CPRA

• 10/25/2022 - a year ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 1/25/2022 - 2 years ago

  4 - TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Type: TAEA

• 1/25/2022 - 2 years ago

  3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 1/24/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/20/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP